Atopic Dermatitis: Promising Data for New Mechanistic Approach

(MedPage Today) -- BOSTON--A new mechanistic strategy for atopic dermatitis reduced disease activity by as much as 60% within 8 weeks in a preliminary clinical evaluation.
Patients treated with the two highest doses of eblasakimab had 61...